EcoDrugPlus

Insulin-Like Growth Factor 1a Receptor

Ensembl ID : ENSEEEG00000021572
Gene Symbol: IGF1RA
2 Cross references
206 Possible Orthologues:

Insulin-Like Growth Factor 1b Receptor

Ensembl ID : ENSEEEG00000000219
Gene Symbol: IGF1RB
4 Cross references
204 Possible Orthologues:

Integrin Beta 3a

Ensembl ID : ENSEEEG00000008566
Gene Symbol: ITGB3A
4 Cross references
204 Possible Orthologues:

Integrin Beta 3b

Ensembl ID : ENSEEEG00000017617
Gene Symbol: ITGB3B
4 Cross references
195 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSEEEG00000009088
Gene Symbol: LOC113568006
4 Cross references
221 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSEEEG00000005693
Gene Symbol: ITGA4
4 Cross references
226 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSEEEG00000014592
Gene Symbol: ITGB6
4 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSEEEG00000005522
Gene Symbol: ITGB8
1 Cross references
207 Possible Orthologues:

Integrin, Alpha 2b

Ensembl ID : ENSEEEG00000009185
Gene Symbol: ITGA2B
4 Cross references
191 Possible Orthologues:

Integrin, Alpha 5 (Fibronectin Receptor, Alpha Polypeptide)

Ensembl ID : ENSEEEG00000000627
Gene Symbol: ITGA5
2 Cross references
206 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSEEEG00000011116
Gene Symbol: ITGAV
4 Cross references
238 Possible Orthologues:

Integrin, Beta 1a

Ensembl ID : ENSEEEG00000007730
Gene Symbol: ITGB1A
4 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).